Mr C, I cannot remember reading anything about dose duration for the TBI trials.
From Bell Potter Report
30th July 2015
Page 3
Longer dosing duration may be explored: NEU could also explore a longer dosing duration (more than 28 days) than that used in the Phase II trial, however without additional toxicology studies it’s unlikely that they would extend it beyond an additional week or two. The company has not spelt out their intention on this point in the release.
Ann: Half Yearly Report and Accounts 30 June 2015, page-5
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.96 |
Change
-0.140(1.07%) |
Mkt cap ! $1.612B | |||
| Open | High | Low | Value | Volume |
| $13.20 | $13.36 | $12.82 | $4.627M | 354.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7585 | $12.96 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.03 | 3344 | 2 |
View Market Depth
| Last trade - 16.10pm 16/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |